Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information

Detalles Bibliográficos
Autores principales: Talamonti, Marina, Galluzzo, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475382/
https://www.ncbi.nlm.nih.gov/pubmed/32953771
http://dx.doi.org/10.21037/atm.2020.04.05
_version_ 1783579492095098880
author Talamonti, Marina
Galluzzo, Marco
author_facet Talamonti, Marina
Galluzzo, Marco
author_sort Talamonti, Marina
collection PubMed
description
format Online
Article
Text
id pubmed-7475382
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-74753822020-09-17 Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information Talamonti, Marina Galluzzo, Marco Ann Transl Med Editorial Commentary AME Publishing Company 2020-08 /pmc/articles/PMC7475382/ /pubmed/32953771 http://dx.doi.org/10.21037/atm.2020.04.05 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Talamonti, Marina
Galluzzo, Marco
Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
title Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
title_full Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
title_fullStr Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
title_full_unstemmed Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
title_short Importance of genotyping patients for HLA-C*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
title_sort importance of genotyping patients for hla-c*06:02: it provides not only pharmacogenetics implication in response to biologics drugs but also drug survival and drug-related costs information
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475382/
https://www.ncbi.nlm.nih.gov/pubmed/32953771
http://dx.doi.org/10.21037/atm.2020.04.05
work_keys_str_mv AT talamontimarina importanceofgenotypingpatientsforhlac0602itprovidesnotonlypharmacogeneticsimplicationinresponsetobiologicsdrugsbutalsodrugsurvivalanddrugrelatedcostsinformation
AT galluzzomarco importanceofgenotypingpatientsforhlac0602itprovidesnotonlypharmacogeneticsimplicationinresponsetobiologicsdrugsbutalsodrugsurvivalanddrugrelatedcostsinformation

Ejemplares similares